Investor Update Reminder: Invitation to Roche's Virtual Event "Digitalization along the value chain"


We are pleased to invite investors and analysts to participate in a live webinar on Wednesday,
17 November 2021,
highlighting Roche's development in digital technology, data and advanced analytics.

16:00 - 17:30 CET / 15:00 - 16:30 GMT
10:00 - 11:30 am EST / 07:00 - 08:30 am PST

The webinar will be hosted by Alan Hippe, Chief Financial and IT Officer, and other senior leaders in the space followed by a Q&A session.

The event will outline the overall strategy and highlight >20 use cases (including launched products) from the pharmaceuticals & diagnostics divisions. Use cases presented will cover the entire traditional value chain (early R&D, clinical development, regulatory & reimbursement, manufacturing, commercialization, diagnosis) as well as novel treatment/decision support solutions for physicians and patients.

Presenters include:

  • Alan Hippe, Chief Financial and IT Officer Roche
  • Mark McCarthy, Executive Director, Human Genetics, gRED
  • Christian Gossens, Digital Biomarkers, Global Area Head, pRED
  • Jacqueline Law, Vice president, Head of Corporate Strategy, Flatiron Health
  • Steve Guise, Global Head, Pharma Informatics
  • Moritz Hartmann, Global Head of Roche Information Solutions, Roche Diagnostics

The slides will be available for download at 15:00 CET on the day of the event. > click here

We would like to invite all interested parties to participate in the webinar and to pre-register here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webcast will be available via >ir.roche.com

*privacy notice

Best regards,

Karl Mahler
Head of Investor Relations



Bruno Eschli
Investor Relations Officer


Gerard Tobin
Investor Relations Officer
Roche Investor Relations
Dr. Karl Mahler
Phone: +41 61 68-78503
e-mail: karl.mahler@roche.com

Jon Kaspar Bayard
Phone: +41 61 68-83894
e-mail: jon_kaspar.bayard@roche.com
Dr. Sabine Borngräber
Phone: +41 61 68-88027
e-mail: sabine.borngraeber@roche.com

Dr. Bruno Eschli
Phone: +41 61 68-75284
e-mail: bruno.eschli@roche.com
Dr. Birgit Masjost
Phone: +41 61 68-84814
e-mail: birgit.masjost@roche.com
Dr. Gerard Tobin
Phone: +41 61 68-72942
e-mail: gerard.tobin@roche.com
Investor Relations North America
Loren Kalm
Phone: +1 650 225 3217
e-mail: kalm.loren@gene.com

Attachments

  • Original document
  • Permalink

Disclaimer

Roche Holding AG published this content on 11 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 November 2021 13:06:02 UTC.